Artificial Tears Market Outlook to 2024: Global Strategic Business Report 2018 - Preference for Preservative-Free Artificial Tears on Rise - ResearchAndMarkets.com

August 17, 2018

DUBLIN--(BUSINESS WIRE)--Aug 17, 2018--The “Artificial Tears - Global Strategic Business Report” report has been added to ResearchAndMarkets.com’s offering.

The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2016 through 2024. Also, a five-year historic analysis is provided for these markets.

This report analyzes the worldwide markets for Artificial Tears in US$ Thousand.

The report profiles 49 companies including many key and niche players such as:

Akorn, Inc. (USA) Alcon, Inc. (Switzerland) Allergan plc (Ireland) Bausch & Lomb Incorporated (USA) Johnson & Johnson (USA) Novartis International AG (Switzerland) Santen Pharmaceuticals Co, Ltd. (Japan)

Key Topics Covered

1. Introduction, Methodology & Product Definitions

2. Industry Overview

3. Noteworthy Market Trends

Companies Focus on New Formulations to Improve Results Preference for Preservative-Free Artificial Tears on Rise Management of Dry Eyes Post Eye Surgery Drives Demand for Artificial Tears Rise in Mobile Workforce and Number of Smartphone Addicts Spurs Growth Prospects An Upswing in Contact Lens Wearers Unfolds New Opportunities Manufacturers Focus Efforts on Formulating the Right Artificial Tears for Contact Lens Wearers Environmental Factors Play an Important Role Nanotechnology and Other Innovative Delivery Techniques Gain Attention in DES Treatment Direct-to-Customer Promotions: A Primary Marketing Strategy

4. Dry Eye Syndrome - An Overview

5. Product Overview

6. Competitive Landscape

6.1 Focus on Select Global Players

6.2 Product Launches/Approvals/Introductions

6.3 Recent Industry Activity

7. Global Market Perspective

Total Companies Profiled: 49 (including Divisions/Subsidiaries - 54)

The United States (19) Canada (3) Japan (3) Europe (14) France (1)Germany (3)The United Kingdom (3)Italy (1)Spain (1)Rest of Europe (9) Asia-Pacific (Excluding Japan) (12) Middle East (1) Africa (2)

For more information about this report visit https://www.researchandmarkets.com/research/9dz3st/artificial_tears?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20180817005094/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Manager


For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Optical ,Optical Disorders Drugs



SOURCE: Research and Markets

Copyright Business Wire 2018.

PUB: 08/17/2018 04:28 AM/DISC: 08/17/2018 04:28 AM


Update hourly